The clinical effectiveness and cost-effectiveness of home-based, nurse-led health promotion for older people: A systematic review

School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.
Health technology assessment (Winchester, England) 04/2012; 16(20):1-72. DOI: 10.3310/hta16200
Source: PubMed


In older age, reduction in physical function can lead to loss of independence, the need for hospital and long-term nursing or residential home care, and premature death. Home-visiting programmes for older people, carried out by nurses and other health-care professionals (e.g. occupational therapists and physiotherapists), aim to positively affect health and functional status, and may promote independent functioning of older people.
The main research question addressed by this assessment is 'What is the clinical effectiveness and cost-effectiveness of home-based, nurse-led health promotion intervention for older people in the UK?'
A comprehensive literature search was undertaken across 12 different databases and research registries from the year 2001 onwards (including MEDLINE, MEDLINE in Process & Other Non-Indexed Citations, EMBASE, Science Citation Index Expanded, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, NHS Health Economic Evaluation Database, Health Technology Assessment Database, Database of Abstracts of Reviews of Effects, Cumulative Index to Nursing and Allied Health Literature). Published systematic reviews were also hand searched to identify other trials previously published.
Potentially relevant studies were sifted by one reviewer, and inclusion decisions were agreed among the broader research team. The methodological quality of included studies was assessed using the Cochrane Risk of Bias tool. The results of included studies were synthesised using narrative and statistical methods. A separate systematic search was undertaken to identify existing health economic analyses of home-based, nurse-led health promotion programmes. Included studies were critically appraised using a published checklist. Owing to resource constraints, a de novo health economic model was not developed.
Eleven studies were included in the systematic review of clinical effectiveness. There was considerable heterogeneity among the studies with respect to the nature of the intervention, the nurses delivering the programmes and the populations in which the interventions were assessed. Overall, the quality of the included studies was good: all but one of the included studies were judged to be at medium or low risk of bias. Meta-analysis of eight studies suggested a statistically significant mortality benefit for the home-based health promotion groups, whereas a meta-analysis of four studies suggested non-significant benefits in terms of fewer falls in the intervention groups than in the control groups. Positive outcomes for home-based, nurse-led health promotion interventions were also reported within individual studies across several other outcomes. Only three economic studies met the criteria for inclusion in the review of cost-effectiveness. This evidence base consists of one non-randomised cost minimisation analysis and two economic evaluations undertaken alongside randomised controlled trials. Two of these studies involved an intervention targeted specifically at patients with a known underlying incurable disease, whereas the third study examined the clinical effectiveness and cost-effectiveness of early discharge in patients with a range of conditions, including fractures, neurological conditions and cardiorespiratory conditions. Each study indicated some likelihood that home-based, nurse-led health promotion may offer cost savings to the NHS and associated sectors, such as social services. However, one study did not report any comparison of health outcomes and instead simply assumed equivalence between the intervention and comparator groups, whereas the other two studies suggested at best a negligible incremental benefit in terms of preference-based health-related quality-of-life measures.
The evidence base for clinical effectiveness is subject to considerable heterogeneity. The UK economic evidence base is limited to three studies.
On the basis of the evidence included in this systematic review, home-based, nurse-led health promotion may offer clinical benefits across a number of important health dimensions. However, it is generally unclear from the available studies which components of this type of complex intervention contribute towards individual aspects of benefit for older people. Given the limitations of the current evidence base, it remains unclear whether or not home-based health promotion interventions offer good value for money for the NHS and associated sectors. Given the considerable uncertainties in the available evidence base, it is difficult to isolate the key areas in which future research would be valuable or the exact study design required. Although this report does not identify specific studies that should be undertaken, it does set out a number of key considerations for the design of future research in this area.
PROSPERO number: CRD42012002133.

11 Reads
    • "A prospective study that regularly monitors patient changes would produce more valid data and reduce instances of data being unavailable. Assessing elderly persons with comorbidities is challenging, and in such cases, it is difficult to control the confounders that could have affected the patients' health, due to the complexity of the interventions for the elderly [20]. We now have a better view of the HMP's achievements and its contribution to reducing hospital utilization and healthcare costs. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This was an evaluation of home respiratory therapy (HRT) services administered through the Madinah Home Medical Program (MHMP) Center of the Ministry of Health (MoH), Kingdom of Saudi Arabia (KSA). Using a retrospective design and descriptive analyses, we analyzed 83 patient records for the clinical care received, outcomes, and patient satisfaction. We also assessed a subset from an economic perspective. Demographically, 72% were >60years of age, 80% were female, and 90% were Saudi. Asthma accounted for 34% of the diagnosed respiratory diseases, followed by chronic obstructive pulmonary disease (11%). Most patients (71%) required two or three respiratory modalities: 94% used oxygen therapy and 14% were on mechanical ventilation. A full 90% of HMP patients expressed a high level of satisfaction with the HMP overall care, and 43% saw an improvement in their condition. The MHMP lowered healthcare costs for HRT-receiving patients by decreasing the frequency of emergency room (ER) and outpatient visits by 50.8% from 59 to 30 visits. HRT administered through the MHMP Center improved clinical outcomes and increased patient satisfaction while reducing hospital utilization and associated costs. A prospective study is recommended to assess HMP services in comparison with hospitalization. Copyright © 2015. Published by Elsevier Ltd.
    08/2015; DOI:10.1016/j.jegh.2015.07.006
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Systematic review on the effect of preventive home visits to the elderly on self-rated health and quality of life Background: Preventive home visits are offered by a number of municipa-lities in Norway to enable the elderly to stay at home. The effect of pre-ventive home visits have been synt-hesised earlier concerning physical function, admittance to institution and death, but not regarding self-rated health and quality of life. Objective: To assess the effect of pre-ventive home visits to the elderly on self-rated health and quality of life. Method: We searched in AMED, CEN-TRAL, Cinahl, EMBASE, MEDLINE and Svemed+, in reference-lists, and contacted scientists. We critically appraised the included studies using The Cochrane Collaboration's «Risk of bias tool». The results were sum-marised in a narrative syntheses and we assessed the robustness of the results using «The Grading of Recom-mendations Assessment, Develop-ment and Evaluation». Results: Seven studies including 4,833 elderly met the inclusion criteria. Five studies measured self-rated health and three measured quality of life. One out of five studies reported a significant effect on self-rated health, and one out of three studies has a significant effect on quality of life. None of the included studies had serious risksof bias. The quality of the collected evidenceis low. Conclusion: Two studies showed a small positive effect of preventive home visits and no studies reported negative effects. If the health visitors were part of an interdisciplinary team with special competence to implement the preventive home visits, this seems to correlate with positive effects.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: We examined the impact of a prolonged secondary prevention program on recurrent hospitalization in cardiac patients with private health insurance. Methods and results: The Young at Heart multicenter, randomized, controlled trial compared usual postdischarge care (UC) with nurse-led, home-based intervention (HBI). The primary end point was rate of all-cause hospital stay (31.5±7.5 months follow-up). In total, 602 patients (aged 70±10 years, 72% men) were randomized to UC (n=296) or HBI (n=306, 96% received ≥1 home visit). Overall, 42 patients (7.0%) died, and 492 patients (82%) accumulated 2397 all-cause hospitalizations associated with 10,258 hospital days costing >$17 million. There were minimal group differences (HBI versus UC) in the primary end point of all-cause hospital stay (5405 versus 4853 days; median [interquartile range], 0.08 [0.03-0.17] versus 0.07 [0.03-0.13]/patient per month). There were similar trends with respect to all hospitalizations (1197 versus 1200; P=0.802) and associated costs ($8.66 versus $8.58 million; P=0.375). At 2 years, however, more HBI versus UC (39% versus 27%; odds ratio, 1.67; 95% confidence interval, 1.15-2.41; P=0.007) patients were assessed as stable and optimally managed. For women, HBI outcomes were predominantly worse than UC outcomes. In men, HBI was associated with reduced risk of cardiovascular hospitalization (adjusted hazard ratio, 0.68; 95% confidence interval, 0.46-0.99; P=0.044) with less cardiovascular hospitalizations (192 versus 269; P=0.054) and costs ($2.49 versus $3.53 million; P=0.046). Conclusions: HBI did not reduce recurrent all-cause hospitalization compared with UC in privately insured cardiac patients overall. However, it did convey some benefits in cardiac outcomes for men. Clinical trial registration: Australian New Zealand Clinical Trials Registry Unique Identifier: 12608000014358. URL:
    Circulation Cardiovascular Quality and Outcomes 07/2013; 6(4). DOI:10.1161/CIRCOUTCOMES.111.000006 · 5.66 Impact Factor
Show more